Synopsis
Cardiovascular disease remains the leading cause of
mortality in the western World. MR is non-invasive, safe, operates without ionizing
radiation, provides a high soft tissue contrast, and informs about anatomy,
flow, function, tissue properties, and metabolism. Therefore, MR is a powerful
tool for the management of cardiovascular disease. However, to harvest its full
potential, improved ease-of-use, reduced operator dependency, improved time
efficiency, as well as accurate and precise quantitative information about
anatomy, flow, function and tissue properties needs to be provided. With
rapidly evolving technology, some of these above gaps can be bridged and
selected solutions will be discussed.
Background
Despite major
advances in prevention, diagnosis and therapy over the past few decades,
cardiovascular disease remains the leading cause of death in industrialized
nations. Many powerful imaging modalities aimed at probing the health of the
heart have emerged and have been further developed by both industry and
academia. These include, but are not limited to echocardiography, positron
emission tomography (PET), single-photon emission computed tomography (SPECT),
x-ray angiography, computed tomography (CT), and magnetic resonance (MR). More recently,
and owing to the fact that close to 50% of cardiovascular disease can be
attributed to coronary heart disease, fractional flow reserve (FFR), a
technique that includes invasive pressure measurements under x-ray guidance,
has also emerged as a tool to determine the likelihood that a coronary stenosis
impedes oxygen delivery to the heart muscle. However, many of the above
techniques are either invasive or involve potentially harmful ionizing
radiation. Therefore, MR provides an extremely attractive non-invasive
alternative that simultaneously provides a high soft tissue contrast without
x-ray exposure for neither operator nor patient, and that informs about
anatomy, function, blood flow, and even tissue characteristics. However, MR signals
are relatively weak, and the heart is subject to both cardiac and respiratory
motion. These characteristics prohibit real-time data collection with sufficient
temporal resolution, spatial resolution, and volumetric coverage. As a result,
cardiac MR data acquisition has to be segmented and synchronized to both the
rhythm of the heartbeat and to respiration, and the procedure is commonly
performed over a number of consecutive cardiac cycles to avoid blurring in the
images and to maximize the diagnostic yield.Unmet needs
The
relatively complex anatomy of the heart mandates meticulous plan scanning
procedures and ECG lead placement. This costs time and requires skilled
operators. The need for ECG gating or triggering together with strategies aimed
at respiratory motion suppression makes cardiac MR data acquisition even more
time consuming. For some procedures, where the anatomy of the heart is imaged
with high spatial and temporal resolution, data collection efficiency (time during
which data are sampled divided by time spent for the scan) can be as low as 2%,
provided that most time is spent waiting for the next quiescent period of the
heart to occur. However, this makes cardiac MR very time inefficient, prolongs
scanning time, decreases patient comfort, and ultimately contributes to higher
costs for cardiac MR. Then, and as MR
provides the unique opportunity for quantification of tissue characteristics,
function, and blood flow, standardization, accuracy, precision, repeatability
and reproducibility among different centers, across different vendor platforms,
and on different field strengths provide another formidable challenge.
Therefore, improved ease-of-use with reduced operator dependency, improved time
efficiency with shortened examination times, as well as established standardization
procedures are among the unmet needs.Where do we come from?
Over
the past two or three decades, major steps in MR development that helped
address some of the above needs have been undertaken by both academia and
industry. With the development of performant gradient systems, the until then
dormant steady state with free precession (SSFP) approach moved into focus
again and permitted an unprecedented quality in that signal and contrast
between the myocardium and the blood pool was significantly enhanced in an
unprecedented manner. To this day SSFP or balanced SSFP (bSSFP) have become a
work horse in cardiac MRI. With the development of coil arrays and multiple
receiver channels, parallel imaging became possible two decades ago and helped
abbreviate scan times significantly. Then, with the intravenous injection of
contrast media together with sophisticated timing of k-space data acquisition,
the blood vessels could be visualized with unprecedented clarity and in
conjunction with inversion recovery, location, extent, and transmurality of
scar tissue could be characterized. Simultaneously, and owing to more
performant gradients, parallel imaging and contrast injection, first pass
perfusion imaging at rest and during stress became a reality. Finally,
quantitative methods that help better characterize ventricular function, blood
flow, anatomy, and regional tissue properties have emerged and continue to be
developed at a staggering pace.Where do we go?
Clearly,
and with the aim provide access to a larger pool of operators and patients that
are increasingly located outside of academic centers, to improve time
efficiency of the exam, and to extract actionable, relevant, accurate and
precise numbers, further innovation in the domains of data acquisition, reconstruction,
and post processing/analysis is mandatory. Non-ECG triggered, uninterrupted free-breathing
and fully self-navigated 3D radial data acquisition may help remove a good
number of the above-mentioned hurdles. First, plan scanning is reduced to the
placement of a 3D volume in the region of the heart while ECG lead placement
and individually dependent double oblique scan plane orientation as well as breath-holding
are no longer needed. This supports a significantly improved ease-of-use and
will likely improve reproducibility. Secondly, time efficiency will be improved
by an order of magnitude and will support shortened scanning times and improved
patient comfort. Thirdly, with the addition of compressed sensing reconstructions
that are guided by self-gating signals extracted from the acquired k-space data
or from a more recently introduced Pilot Tone concept, we will be empowered to flexibly
interrogate such datasets retrospectively, freely, and in 3D. This will shift
the paradigm from “plan and scan” to “scan now and ask questions later”.
Consistent with this general idea, “Fingerprinting” and “Multi Tasking” provide
original, novel, and exciting opportunities and hold the promise to extract quantitative
information to additionally characterize regional tissue properties and blood
flow with high accuracy, precision, reproducibility, and flexibility. Clearly,
artificial intelligence, new devices, and hardware for interventions as well as
continuous and stunning advances in computing power currently provide
unprecedented opportunities to further push the envelope, to make new
scientific discoveries, to add diagnostic and therapeutic value, and to
generally expand the field of cardiac MR.Acknowledgements
No acknowledgement found.References
No reference found.